Risperidone: clinical development: north American results
- PMID: 1379883
- DOI: 10.1097/00002826-199201001-00049
Risperidone: clinical development: north American results
Abstract
This multicenter trial indicates that risperidone is an effective treatment for the positive and negative symptoms of schizophrenia. The most effective dose appears to be about 6 mg of risperidone daily. This dose was more effective than 20 mg of haloperidol. In addition, this dose was associated with very low rates of extrapyramidal side effects.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical